FDA Investigator CDR Cecily Jones
CDR Cecily Jones has inspections in 2 countries as of 01 Jun 2023. CDR Cecily Jones has collaborated with a combinined 819 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
01 Jun 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Mexico
Co-Investigator(s):
Anissa M Cheung,
Anthony F Lorenzo,
Brandon L Blakely,
Brentley S Collins,
CDR Donald Ertel,
CDR Jeremy L Wally, PhD,
Cecily Javes,
Christine I Shaw,
Daniel J Lahar,
Gene D Arcy,
Haruhiko Murata,
Jacqueline Mdiaz Albertini,
Janet Pulver,
Jean Lhu Primmer,
Joey V Quitania,
Joshua E Yao,
Lilia Bi, PhD,
Michael C Kennedy, PhD,
Michael J Vardon,
Minh D Phan,
Monica J Wilkins,
Pankaj H Amin,
Paul D Keller,
Paul W Keller,
Penny H Mccarver,
Prabhu P Raju,
Priscilla M Pastrana,
Rabia Ballica, PhD,
Randa Melhem, PhD,
Robert D Tollefsen,
Scott K Zika,
Shaquenta Y Perkins,
Simone E Pitts,
Sonya L Karsik,
Steven A Rubin,
Steven E Bowen, PhD,
Susan M Jackson,
Timothy P Lafave,
Trudy R Papson,
Virgilio F Pacio, CSO,
Xianghong Jing (Emily), PhD,
Xiao Wang,
Yvette E Guillermo,
Zenobia Taraporewala,
Zeuchia Tarapstewaka, PhD
CDR Cecily Jones's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2020 | FDA 483 | Respironics California, LLC - Form 483, 2020-01-10 |
February, 2014 | FDA 483 | Seqirus Inc - Form 483, 2014-02-12 |
August, 2017 | FDA 483 | Spark Therapeutics, Inc. - Form 483, 2017-08-25 |
August, 2017 | EIR | Spark Therapeutics, Inc. - EIR, 2017-08-25 |
August, 2017 | FDA 483 Response | Spark Therapeutics, Inc. - Form 483R, 2017-09-08 |
August, 2018 | FDA 483 | Laboratorios Silanes, S.A. de C.V. - Form 483, 2018-08-03 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more